LAPONITE® nanodisk-based platforms for cancer diagnosis and therapy

3Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Recent advances in nanomedicine are rapidly extending the boundaries of biomedical technologies, particularly in tumor diagnosis and therapy. As a typical two-dimensional nanomaterial, LAPONITE® (LAP) has attracted much attention due to its good biocompatibility, colloidal stability, high specific surface area, and easiness of surface functionalization. Considerable progress has been made in the development of various LAP-based nanoplatforms for tumor diagnosis, treatment, and theranostics. In this review, we survey the recent advances in the development of various LAP-based drug delivery systems that have been used for tumor chemotherapy and phototherapy, tumor imaging, and tumor theranostics. The challenges and future development strategies for LAP-based nanomedicines toward practical biomedical applications are also discussed.

Cite

CITATION STYLE

APA

Li, G., Guo, Y., Guo, R., Shi, X., & Shen, M. (2022, July 20). LAPONITE® nanodisk-based platforms for cancer diagnosis and therapy. Materials Advances. Royal Society of Chemistry. https://doi.org/10.1039/d2ma00637e

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free